114 related articles for article (PubMed ID: 1679183)
1. Use of ketorolac in sickle-cell disease and vaso-occlusive crisis.
Goodman E
Lancet; 1991 Sep; 338(8767):641-2. PubMed ID: 1679183
[No Abstract] [Full Text] [Related]
2. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.
Sanders DY; Severance HW; Pollack CV
South Med J; 1992 Aug; 85(8):808-11. PubMed ID: 1302470
[TBL] [Abstract][Full Text] [Related]
4. Meperidine and ketorolac in the treatment of painful sickle cell crisis.
Richardson P; Steingart R
Ann Emerg Med; 1993 Oct; 22(10):1639-40. PubMed ID: 8214851
[No Abstract] [Full Text] [Related]
5. Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect.
Wright SW; Norris RL; Mitchell TR
Ann Emerg Med; 1992 Aug; 21(8):925-8. PubMed ID: 1497158
[TBL] [Abstract][Full Text] [Related]
6. Place of ketorolac in pain management.
Baumann TJ
Clin Pharm; 1990 Dec; 9(12):938. PubMed ID: 2292176
[No Abstract] [Full Text] [Related]
7. Ketorolac: a new drug for relief of acute pain.
Corbett JV; Lagana K
MCN Am J Matern Child Nurs; 1994; 19(4):240. PubMed ID: 7934705
[No Abstract] [Full Text] [Related]
8. Ketorolac: an alternative for the management of acute pain.
Burke SM
MCN Am J Matern Child Nurs; 1997; 22(1):56. PubMed ID: 9002691
[No Abstract] [Full Text] [Related]
9. Ketorolac-induced irreversible renal failure in sickle cell disease: a case report.
Simckes AM; Chen SS; Osorio AV; Garola RE; Woods GM
Pediatr Nephrol; 1999 Jan; 13(1):63-7. PubMed ID: 10100293
[TBL] [Abstract][Full Text] [Related]
10. Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.
Blackwell N; Bangham L; Hughes M; Melzack D; Trotman I
Thorax; 1993 Apr; 48(4):401. PubMed ID: 8511741
[TBL] [Abstract][Full Text] [Related]
11. Pain management with intravenous ketorolac.
Miller LJ; Kramer MA
Ann Pharmacother; 1993 Mar; 27(3):307-8. PubMed ID: 8453167
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of moderate and severe pain. Ketorolac--a new analgesic].
Freie HM
Fortschr Med; 1991 Oct; 109(31):643-6. PubMed ID: 1743610
[TBL] [Abstract][Full Text] [Related]
13. If you have no destination, any road will do.
Todd KH
Acad Emerg Med; 1998 Feb; 5(2):92-3. PubMed ID: 9492125
[No Abstract] [Full Text] [Related]
14. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
15. Ketorolac (Toradol) for dental pain.
Wynn RL
Gen Dent; 1992; 40(6):476-9. PubMed ID: 1298670
[No Abstract] [Full Text] [Related]
16. Comparative study of ketorolac and dipyrone in the treatment of postoperative pain.
Ibarra-Ibarra LG; Cubillo MA; Silva-Adaya A; González-García CA
Proc West Pharmacol Soc; 1993; 36():133-5. PubMed ID: 8378366
[No Abstract] [Full Text] [Related]
17. Comparative study of ketorolac and dipyrone administered orally in the treatment of postoperative pain.
González-García CA; Ibarra-Ibarra LG; Barbosa-Vivanco S
Proc West Pharmacol Soc; 1994; 37():121-2. PubMed ID: 7984640
[No Abstract] [Full Text] [Related]
18. Ketorolac formulary restriction and usage evaluation.
Gianarkis DG
DICP; 1991 Dec; 25(12):1399. PubMed ID: 1844133
[No Abstract] [Full Text] [Related]
19. Ketorolac.
Gupta P
Indian Pediatr; 1994 May; 31(5):575-8. PubMed ID: 7875890
[No Abstract] [Full Text] [Related]
20. Ketorolac (Toradol) induced lithium toxicity.
Iyer V
Headache; 1994; 34(7):442-4. PubMed ID: 7928331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
